Acidosis tubular renal


Artículos principales

Palmer BF, Kelepouris E, Clegg DJ. Renal tubular acidosis and management strategies: a narrative review. Adv Ther. 2021 Feb;38(2):949-68.Texto completo  Resumen

Kashoor I, Batlle D. Proximal renal tubular acidosis with and without Fanconi syndrome. Kidney Res Clin Pract. 2019 Sep 30;38(3):267-81.Texto completo  Resumen

Giglio S, Montini G, Trepiccione F, et al. Distal renal tubular acidosis: a systematic approach from diagnosis to treatment. J Nephrol. 2021 Mar 26 [online ahead of print].Texto completo  Resumen

Rodriguez Soriano J. Renal tubular acidosis: the clinical entity. J Am Soc Nephrol. 2002 Aug;13(8):2160-70.Texto completo  Resumen

Batlle D, Arruda J. Hyperkalemic forms of renal tubular acidosis: clinical and pathophysiological aspects. Adv Chronic Kidney Dis. 2018 Jul;25(4):321-33. Resumen

Soleimani M, Rastegar A. Pathophysiology of renal tubular acidosis: core curriculum 2016. Am J Kidney Dis. 2016 Sep;68(3):488-98.Texto completo  Resumen

Artículos de referencia

1. Palmer BF, Kelepouris E, Clegg DJ. Renal tubular acidosis and management strategies: a narrative review. Adv Ther. 2021 Feb;38(2):949-68.Texto completo  Resumen

2. Kashoor I, Batlle D. Proximal renal tubular acidosis with and without Fanconi syndrome. Kidney Res Clin Pract. 2019 Sep 30;38(3):267-81.Texto completo  Resumen

3. Giglio S, Montini G, Trepiccione F, et al. Distal renal tubular acidosis: a systematic approach from diagnosis to treatment. J Nephrol. 2021 Mar 26 [online ahead of print].Texto completo  Resumen

4. Rodriguez Soriano J. Renal tubular acidosis: the clinical entity. J Am Soc Nephrol. 2002 Aug;13(8):2160-70.Texto completo  Resumen

5. Alexander RT, Law L, Gil-Peña H, et al. Hereditary distal renal tubular acidosis. In: Adam MP, Ardinger HH, Pagon RA, et al, eds. GeneReviews. Seattle (WA): University of Washington, Seattle; Oct 2019 [internet publication].Texto completo  Resumen

6. Fuster DG, Moe OW. Incomplete distal renal tubular acidosis and kidney stones. Adv Chronic Kidney Dis. 2018 Jul;25(4):366-74. Resumen

7. Foreman JW. Fanconi syndrome. Pediatr Clin North Am. 2019 Feb;66(1):159-67. Resumen

8. Besouw MTP, Bienias M, Walsh P, et al. Clinical and molecular aspects of distal renal tubular acidosis in children. Pediatr Nephrol. 2017 Jun;32(6):987-96. Resumen

9. Tatu CA, Orem WH, Finkelman RB, et al. The etiology of Balkan endemic nephropathy: still more questions than answers. Environ Health Perspect. 1998 Nov;106(11):689-700.Texto completo  Resumen

10. Stefanovic V, Plenakovic M. Fifty years of research in Balkan endemic nephropathy: where are we now? Nephron Clin Pract. 2009;112(2):c51-6.Texto completo  Resumen

11. Nimmannit S, Malasit P, Susaengrat W, et al. Prevalence of endemic distal renal tubular acidosis and renal stone in the northeast of Thailand. Nephron. 1996;72(4):604-10. Resumen

12. Pun KK, Wong CK, Tsui EY, et al. Hypokalemic periodic paralysis due to the Sjögren syndrome in Chinese patients. Ann Intern Med. 1989 Mar 1;110(5):405-6. Resumen

13. Bianic F, Guelfucci F, Robin L, et al. Epidemiology of distal renal tubular acidosis: a study using linked UK primary care and hospital data. Nephron. 2021;145(5):486-95. Resumen

14. Mohebbi N, Wagner CA. Pathophysiology, diagnosis and treatment of inherited distal renal tubular acidosis. J Nephrol. 2018 Aug;31(4):511-22. Resumen

15. Karet FE. Inherited distal renal tubular acidosis. J Am Soc Nephrol. 2002 Aug;13(8):2178-84.Texto completo  Resumen

16. Elmonem MA, Veys KR, Soliman NA, et al. Cystinosis: a review. Orphanet J Rare Dis. 2016 Apr 22;11:47.Texto completo  Resumen

17. Senemar S, Ganjekarimi A, Senemar S, et al. The prevalence and clinical study of galactosemia disease in a pilot screening program of neonates, southern iran. Iran J Public Health. 2011 Dec;40(4):99-104.Texto completo  Resumen

18. Palmer BF, Clegg DJ. Hyperchloremic normal gap metabolic acidosis. Minerva Endocrinol. 2019 Dec;44(4):363-77. Resumen

19. Batlle D, Arruda J. Hyperkalemic forms of renal tubular acidosis: clinical and pathophysiological aspects. Adv Chronic Kidney Dis. 2018 Jul;25(4):321-33. Resumen

20. Bello CHPRT, Duarte JS, Vasconcelos C. Diabetes mellitus and hyperkalemic renal tubular acidosis: case reports and literature review. J Bras Nefrol. 2017 Oct-Dec;39(4):481-5.Texto completo  Resumen

21. Schwarz C, Benesch T, Kodras K, et al. Complete renal tubular acidosis late after kidney transplantation. Nephrol Dial Transplant. 2006 Sep;21(9):2615-20.Texto completo  Resumen

22. Kocyigit I, Unal A, Kavuncuoglu F, et al. Renal tubular acidosis in renal transplantation recipients. Ren Fail. 2010 Jul;32(6):687-90. Resumen

23. Online Mendelian Inheritance in Man (OMIM). Fanconi renotubular syndrome 1; FRTS 1: gene map locus 15q15.3. May 2017 [internet publication].Texto completo

24. Patil S, Subramany S, Patil S, et al. Ibuprofen abuse-a case of rhabdomyolysis, hypokalemia, and hypophosphatemia with drug-induced mixed renal tubular acidosis. Kidney Int Rep. 2018 Jun 8;3(5):1237-8.Texto completo  Resumen

25. Ng JL, Morgan DJR, Loh NK, et al. Life-threatening hypokalemia associated with ibuprofen-induced renal tubular acidosis. Med J Aust. 2011 Mar 21;194(6):313-6. Resumen

26. Medland NA, Chow EP, Walker RG, et al. Incidence of renal Fanconi syndrome in patients taking antiretroviral therapy including tenofovir disoproxil fumarate. Int J STD AIDS. 2018 Mar;29(3):227-36. Resumen

27. Palazzo V, Provenzano A, Becherucci F, et al. The genetic and clinical spectrum of a large cohort of patients with distal renal tubular acidosis. Kidney Int. 2017 May;91(5):1243-55. Resumen

28. Watanabe T. Improving outcomes for patients with distal renal tubular acidosis: recent advances and challenges ahead. Pediatric Health Med Ther. 2018 Dec 12;9:181-90.Texto completo  Resumen

29. Alexander RT, Bitzan M. Renal tubular acidosis. Pediatr Clin North Am. 2019 Feb;66(1):135-57. Resumen

30. El Bitar S, Weerasinghe C, El-Charabaty E, et al. Renal tubular acidosis an adverse effect of PD-1 inhibitor immunotherapy. Case Rep Oncol Med. 2018 Jan 31;2018:8408015.Texto completo  Resumen

31. Kaplan MM. Primary biliary cirrhosis. N Engl J Med. 1996 Nov 21;335(21):1570-80. Resumen

32. Haque SK, Ariceta G, Battle G. Proximal renal tubular acidosis: a not so rare disorder of multiple etiologies. Nephrol Dial Transplant. 2012 Dec;27(12):4273-87.Texto completo  Resumen

33. Sly WS, Hewett-Emmett D, Whyte MP, et al. Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. Proc Natl Acad Sci U S A. 1983 May;80(9):2752-6. Resumen

34. Sly WS, Whyte MP, Sundaram V, et al. Carbonic anhydrase II deficiency in 12 families with the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. N Engl J Med. 1985 Jul 18;313(3):139-45. Resumen

35. Batlle D, Moorthi KM, Schluter W, et al. Distal renal tubular acidosis and the potassium enigma. Semin Nephrol. 2006 Nov;26(6):471-8. Resumen

36. Karet FE, Finberg KE, Nelson RD, et al: Mutations in the gene encoding the B1 subunit of H+-ATPase cause renal tubular acidosis with sensorineural deafness. Nat Genet. 1999 Jan;21(1):84-90. Resumen

37. Smith AN, Skaug J, Choate KA, et al. Mutations in ATP6N1B, encoding a new kidney vacuolar proton pump 116-kD subunit, cause recessive distal renal tubular acidosis with preserved hearing. Nat Genet. 2000 Sep;26(1):71-5. Resumen

38. Zhang J, Fuster DG, Cameron MA, et al. Incomplete distal renal tubular acidosis from a heterozygous mutation of the V-ATPase B1 subunit. Am J Physiol Renal Physiol. 2014 Nov 1;307(9):F1063-71.Texto completo  Resumen

39. Kurtz I. Renal tubular acidosis: H+/base and ammonia transport abnormalities and clinical syndromes. Adv Chronic Kidney Dis. 2018 Jul;25(4):334-50.Texto completo  Resumen

40. Karet FE, Gainza FJ, Gyory AZ, et al. Mutations in the chloride-bicarbonate exchanger gene AE1 cause autosomal dominant but not autosomal recessive distal renal tubular acidosis. Proc Natl Acad Sci U S A. 1998 May 26;95(11):6337-42. Resumen

41. Morris RC Jr. Renal tubular acidosis. Mechanisms, classification and implications. N Engl J Med. 1969 Dec 18;281(25):1405-13. Resumen

42. Igarashi T, Inatomi J, Sekine T, et al. Mutations in SLC4A4 cause permanent isolated proximal renal tubular acidosis with ocular abnormalities. Nat Genet. 1999 Nov;23(3):264-6. Resumen

43. Bernarado AA, Bernardo CM, Espiritu DJ, et al. The sodium bicarbonate cotransporter: structure, function, and regulation. Semin Nephrol. 2006 Sep;26(5):352-60. Resumen

44. Magen D, Berger L, Coady MJ, et al. A loss-of-function mutation in NaPi-IIa and renal Fanconi's syndrome. N Engl J Med. 2010 Mar 25;362(12):1102-9.Texto completo  Resumen

45. Morimoto T, Uchida S, Sakamoto H, et al. Mutations in CLCN5 chloride channel in Japanese patients with low molecular weight proteinuria. J Am Soc Nephrol. 1998 May;9(5):811-8.Texto completo  Resumen

46. Lowe M. Structure and function of the Lowe syndrome protein OCRL1. Traffic. 2005 Sep;6(9):711-9.Texto completo  Resumen

47. Choudhury R, Diao A, Zhang F, et al. Lowe syndrome protein OCRL1 interacts with clathrin and regulates protein trafficking between endosomes and the trans-Golgi network. Mol Biol Cell. 2005 Aug;16(8):3467-79.Texto completo  Resumen

48. Klootwijk ED, Reichold M, Helip-Wooley A, et al. Mistargeting of peroxisomal EHHADH and inherited renal Fanconi's syndrome. N Engl J Med. 2014 Jan 9;370(2):129-38. Resumen

49. Sacré A, Jouret F, Manicourt D, et al. Topiramate induces type 3 renal tubular acidosis by inhibiting renal carbonic anhydrase. Nephrol Dial Transplant. 2006 Oct;21(10):2995-6.Texto completo  Resumen

50. Palmer BF. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med. 2004 Aug 5;351(6):585-92. Resumen

51. Sastrasinh S, Tannen RL. Effect of potassium on renal NH3 production. Am J Physiol. 1983 Apr;244(4):F383-91. Resumen

52. Andersen OS, Silveira JE, Steinmetz PR. Intrinsic characteristics of the proton pump in the luminal membrane of a tight urinary epithelium. The relation between transport rate and delta mu H. J Gen Physiol. 1985 Aug;86(2):215-34.Texto completo  Resumen

53. Lopez-Garcia SC, Emma F, Walsh SB, et al. Treatment and long-term outcome in primary distal renal tubular acidosis. Nephrol Dial Transplant. 2019 Jun 1;34(6):981-91. Resumen

54. Batlle DC, Arruda JA, Kurtzman NA. Hyperkalemic distal renal tubular acidosis associated with obstructive uropathy. N Engl J Med. 1981 Feb 12;304(7):373-80. Resumen

55. Thirakomen K, Kozlov N, Arruda JA, et al. Renal hydrogen ion secretion after release of unilateral ureteral obstruction. Am J Physiol. 1976 Oct;231(4):1233-9. Resumen

56. Hanley MJ, Davidson K. Isolated nephron segments from rabbit models of obstructive nephropathy. J Clin Invest. 1982 Jan;69(1):165-74. Resumen

57. Sabatini S, Kurtzman NA. Enzyme activity in obstructive uropathy: basis for salt wastage and the acidification defect. Kidney Int. 1990 Jan;37(1):79-84. Resumen

58. Sebastian A, Schambelan M, Lindenfeld S, et al. Amelioration of metabolic acidosis with fludrocortisone therapy in hyporeninemic hypoaldosteronism. N Engl J Med. 1977 Sep 15;297(11):576-83. Resumen

59. Sebastian A, Schambelan M, Sutton JM. Amelioration of hyperchloremic acidosis with furosemide therapy in patients with chronic renal insufficiency and type 4 renal tubular acidosis. Am J Nephrol. 1984;4(5):287-300. Resumen

60. Brenner RJ, Spring DB, Sebastian A, et al. Incidence of radiographically evident bone disease, nephrocalcinosis, and nephrolithiasis in various types of renal tubular acidosis. N Engl J Med. 1982 Jul 22;307(4):217-21. Resumen

61. Higashihara E, Nutahara K, Tago K, et al. Medullary sponge kidney and renal acidification defect. Kidney Int. 1984 Feb;25(2):453-9. Resumen

62. Morris RC, Yamauchi H, Palubinskas AJ, et al. Medullary sponge kidney. Am J Med. 1965 Jun;38:883-92. Resumen

63. Preminger GM, Sakhaee K, Skurla C, et al. Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis. J Urol. 1985 Jul;134(1):20-3. Resumen

64. Buckalew VM Jr, Purvis ML, Shulman MG, et al. Hereditary renal tubular acidosis. Report of a 64 member kindred with variable clinical expression including idiopathic hypercalciuria. Medicine (Baltimore). 1974 Jul;53(4):229-54. Resumen

65. Coe FL, Parks JH. Stone disease in heredity distal renal tubular acidosis. Ann Intern Med. 1980 Jul;93(1):60-1. Resumen

66. McCurdy DK, Frederic M, Elkinton JR. Renal tubular acidosis due to amphotericin B. N Engl J Med. 1968 Jan 18;278(3):124-30. Resumen

67. Patterson RM, Ackerman GL. Renal tubular acidosis due to amphotericin B nephrotoxicity. Arch Intern Med. 1971 Feb;127(2):241-4. Resumen

68. Lee DB, Drinkard JP, Rosen VJ, et al. The adult Fanconi syndrome: observations on etiology, morphology, renal function and mineral metabolism in three patients. Medicine (Baltimore). 1972 Mar;51(2):107-38. Resumen

69. Wegienka LC, Weller JM. Renal tubular acidosis caused by degraded tetracycline. Arch Intern Med. 1964 Aug;114:232-5. Resumen

70. Russo JC, Adelman RD. Gentamicin-induced Fanconi syndrome. J Pediatr. 1980 Jan;96(1):151-3. Resumen

71. Chisolm JJ Jr, Harrison HC, Eberlein WR, et al. Amino-aciduria, hypophosphatemia, and rickets in lead poisoning; study of a case. AMA Am J Dis Child. 1955 Feb;89(2):159-68. Resumen

72. Morris RC Jr. The clinical spectrum of Fanconi's syndrome. Calif Med. 1968;1108:225.

73. Lu M, Holliday LS, Zhang L, et al. Interaction between aldolase and vacuolar H+-ATPase: evidence for direct coupling of glycolysis to the ATP-hydrolyzing proton pump. J Biol Chem. 2001 Aug 10;276(32):30407-13.Texto completo  Resumen

74. Morris RC Jr. An experimental renal acidification defect in patients with hereditary fructose intolerance. II. Its distinction from classic renal tubular acidosis; its resemblance to the renal acidification defect associated with the Fanconi syndrome of children with cystinosis. J Clin Invest. 1968 Jul;47(7):1648-63. Resumen

75. Sokol RJ, Twedt D, McKim JM, et al. Oxidant injury to hepatic mitochondria in patients with Wilson’s disease and Bedlington terriers with copper toxicosis. Gastroenterology. 1994 Dec;107(6):1788-98. Resumen

76. Morgan HG, Stewart WK, Lowe KG, et al. Wilson's disease and the Fanconi syndrome. Q J Med. 1962 Jul;31:361-84. Resumen

77. Cuthbert JA. Wilson’s disease: a new gene and an animal model for an old disease. J Invest Med. 1995 Aug;43(4):323-36. Resumen

78. Holton JB, Walter JH, Tyfield LA. Galactosemia. In: Scriver CR, Beaudet AL, Sly SD, et al, eds. The metabolic and molecular basis of inherited disease. 8th ed. New York, NY: McGraw-Hill; 2001:1553-87.

79. Chen YT. Glycogen storage diseases. In: Scriver CR, Beaudet AL, Sly SD, et al, eds. The metabolic and molecular basis of inherited disease. 8th ed. New York, NY: McGraw-Hill; 2001:1521-51.

80. Spencer AG, Franglen GT. Gross amino-aciduria following a Lysol burn. Lancet. 1952 Jan 26;1(6700):190-2. Resumen

81. Roth KS, Carter BE, Higgins ES. Succinylacetone effects on renal tubular phosphate metabolism: a model for experimental renal Fanconi syndrome. Proc Soc Exp Biol Med. 1991 Apr;196(4):428-31. Resumen

82. Goyer RA, Krall A, Kimball JP. The renal tubule in lead poisoning: II. In vitro studies of mitochondrial structure and function. Lab Invest. 1968 Jul;19(1):78-83. Resumen

83. Nordberg GF, Jin T, Nordberg M. Subcellular targets of cadmium nephrotoxicity: cadmium binding to renal membrane proteins in animals with or without protective metallothionein synthesis. Environ Health Perspect. 1994 Sep;102 Suppl 3:191-4.Texto completo  Resumen

84. Adams RG, Harrison JF, Scott P. The development of cadmium-induced proteinuria, impaired renal function, and osteomalacia in alkaline battery workers. Q J Med. 1969 Oct;38(152):425-43. Resumen

85. Ho PT, Zimmerman K, Wexler LH, et al. A prospective evaluation of ifosfamide-related nephrotoxicity in children and young adults. Cancer. 1995 Dec 15;76(12):2557-64. Resumen

86. Sprangers B, Lapman S. The growing pains of ifosfamide. Clin Kidney J. 2020 Aug;13(4):500-3.Texto completo  Resumen

87. Gahl, WA, Thoene JG, Schneider JA. Cystinosis: a disorder of lysosomal membrane transport. In: Scriver CR, Beaudet AL, Sly SD, et al, eds. The metabolic and molecular basis of inherited disease. 8th ed. New York, NY: McGraw-Hill; 2001:5085-108.

88. Kamel DS, Ethier JH, Quaggin S, et al. Studies to determine the basis of hyperkalemia in recipients of a renal transplant who are treated with cyclosporine. J Am Soc Nephrol. 1992 Feb;2(8):1279-84. Resumen

89. O'Kelly R, Magee F, McKenna TJ. Routine heparin therapy inhibits adrenal aldosterone production. J Clin Endocrinol Metab. 1983 Jan;56(1):108-12. Resumen

90. Batlle D, Gaviria M, Grupp M, et al. Distal nephron function in patients receiving chronic lithium therapy. Kidney Int. 1982 Mar;21(3):477-85. Resumen

91. Batlle DC. Segmental characterization of defects in collecting tubule acidification. Kidney Int. 1986 Oct;30(4):546-54. Resumen

92. Roscoe JM, Goldstein MB, Halperin ML, et al: Lithium-induced impairment of urine acidification. Kidney Int. 1976 Apr;9(4):344-50. Resumen

93. Gabow PA, Moore S, Schrier RW. Spironolactone-induced hyperchloremic acidosis in cirrhosis. Ann Intern Med. 1979 Mar;90(3):338-40. Resumen

94. Kleyman TR, Roberts C, Ling BN. A mechanism for pentamidine-induced hyperkalemia: inhibition of distal nephron sodium transport. Ann Intern Med. 1995 Jan 15;122(2):103-6. Resumen

95. Tan SY, Shapiro R, Franco R, et al. Indomethacin-induced prostaglandin inhibition with hyperkalemia. A reversible cause of hyporeninemic hypoaldosteronism. Ann Intern Med. 1979 May;90(5):783-5. Resumen

96. Choi MJ, Fernandez PC, Patnaik A, et al. Trimethoprim-induced hyperkalemia in a patient with AIDS. N Engl J Med. 1993 Mar 11;328(10):703-6. Resumen

97. Seldin DW, Portwood RM, Rector FC Jr, et al. Characteristics of renal bicarbonate reabsorption in man. J Clin Invest. 1959 Oct;38:1663-71. Resumen

98. Maldonado JE, Velosa JA, Kyle RA, et al. Fanconi syndrome in adults: a manifestation of a latent form of myeloma. Am J Med. 1975 Mar;58(3):354-64. Resumen

99. Rochman J, Lichtig C, Osterweill D, et al. Adult Fanconi's syndrome with renal tubular acidosis in association with renal amyloidosis: occurrence in a patient with chronic lymphocytic leukemia. Arch Intern Med. 1980 Oct;140(10):1361-3. Resumen

100. Wilson DM, Goldstein NP. Bicarbonate excretion in Wilson's disease (hepatolenticular degeneration). Mayo Clin Proc. 1974 Jun;49(6):394-400. Resumen

101. Ahya SN, Jose Soler M, Levitsky J, et al. Acid-base and potassium disorders in liver disease. Semin Nephrol. 2006 Nov;26(6):466-70. Resumen

102. Caruana RJ, Barish CF, Buckalew VM Jr. Complete distal tubular acidosis in systemic lupus: clinical and laboratory findings. Am J Kidney Dis. 1985 Jul;6(1):59-63. Resumen

103. Mason AM, Golding PL. Renal tubular acidosis and autoimmune thyroid disease. Lancet. 1970 Nov 28;2(7683):1104-7. Resumen

104. Jaeger P, Portman L, Wauters JP, et al. Distal renal tubular acidosis and lymphocytic thyroiditis with spontaneously resolving hyperthyroidism. Am J Nephrol. 1985;5(2):116-20. Resumen

105. Batlle DC, Mozes MF, Manaligod J, et al. The pathogenesis of hyperchloremic metabolic acidosis associated with kidney transplantation. Am J Med. 1981 Apr;70(4):786-96. Resumen

106. Cohen EP, Bastani B, Cohen MR, et al. Absence of H(+)-ATPase in cortical collecting tubules of a patient with Sjogren's syndrome and distal renal tubular acidosis. J Am Soc Nephrol. 1992 Aug;3(2):264-71. Resumen

107. DeFranco PE, Haragasim L, Schmitz PG, et al. Absence of vacuolar H(+)-ATPase pump in the collecting duct of a patient with hypokalemic distal renal tubular acidosis and Sjogren's syndrome. J Am Soc Nephrol. 1995 Aug;6(2):295-301. Resumen

108. Dineshkumar T, Myvizhiselvi M, Dhanapriya J, et al. Renal manifestations of primary Sjogren's syndrome. J Integr Nephrol Androl. 2018 Jul-Sept;5(3):109-12.Texto completo

109. Jelaković B, Dika Ž, Arlt VM, et al. Balkan endemic nephropathy and the causative role of aristolochic acid. Semin Nephrol. 2019 May;39(3):284-96. Resumen

110. Stiborová M, Arlt VM, Schmeiser HH. Balkan endemic nephropathy: an update on its aetiology. Arch Toxicol. 2016 Nov;90(11):2595-615.Texto completo  Resumen

111. Kaitwatcharachai C, Vasuvattakul S, Yenchitsomanus P, et al. Distal renal tubular acidosis and high urine carbon dioxide tension in a patient with southeast Asian ovalocytosis. Am J Kidney Dis. 1999 Jun;33(6):1147-52. Resumen

112. Vasuvattakul S, Yenchitsomanus PT, Vachuanichsanong P, et al. Autosomal recessive distal renal tubular acidosis associated with Southeast Asian ovalocytosis. Kidney Int. 1999 Nov;56(5):1674-82. Resumen

113. Tosukhowong P, Tungsanga K, Eiam-Ong S, et al. Environmental distal renal tubular acidosis in Thailand: an enigma. Am J Kidney Dis.1999 Jun;33(6):1180-6. Resumen

114. Vaziri ND, Ness RL, Farishter RD, et al. Nephrotoxicity of paraquat in man. Arch Intern Med.1979 Feb;139(2):172-4. Resumen

115. Moss AH, Gabow PH, Kaehny WD, et al. Fanconi’s syndrome and distal renal tubular acidosis after glue sniffing. Ann Intern Med. 1980 Jan;92(1):69-70. Resumen

116. Lambert AP, Close C. Life-threatening hypokalaemia from abuse of Nurofen plus. J Royal Soc Med. 2005 Jan;98(1):21.Texto completo  Resumen

117. Fontana RJ. Side effects of long-term oral antiviral therapy for hepatitis B. Hepatology. 2009 May;49(5 Suppl):S185-95.Texto completo  Resumen

118. Zhao X, Sun K, Lan Z, et al. Tenofovir and adefovir down-regulate mitochondrial chaperone TRAP1 and succinate dehydrogenase subunit B to metabolically reprogram glucose metabolism and induce nephrotoxicity. Sci Rep. 2017 Apr 11;7:46344.Texto completo  Resumen

119. Vittecoq D, Dumitrescu L, Beaufils H, et al. Fanconi syndrome associated with cidofovir therapy [letter]. Antimicrob Agents Chemother. 1997 Aug;41(8):1846.Texto completo  Resumen

120. Rifkin BS, Perazella MA. Tenofovir-associated nephrotoxicity: Fanconi syndrome and renal failure. Am J Med. 2004 Aug 15;117(4):282-4. Resumen

121. Herrmann SM, Alexander MP, Romero MF, et al. Renal tubular acidosis and immune checkpoint inhibitor therapy: an immune-related adverse event of PD-1 inhibitor - a report of 3 cases. Kidney Med. 2020 Sep-Oct;2(5):657-62.Texto completo  Resumen

122. Botero Aguirre JP, Restrepo Hamid AM. Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney function. Cochrane Database Syst Rev. 2015 Nov 23;(11):CD010481.Texto completo  Resumen

123. Soares SBM, de Menezes Silva LAW, de Carvalho Mrad FC, et al. Distal renal tubular acidosis: genetic causes and management. World J Pediatr. 2019 Oct;15(5):422-31. Resumen

124. Batlle DC, Hizon M, Cohen E, et al. The use of urinary anion gap in the diagnosis of hyperchloremic metabolic acidosis. N Engl J Med. 1988 Mar 10;318(10):594-9. Resumen

125. Oh MS, Carroll HJ. Value and determinants of urine anion gap. Nephron. 2002 Mar;90(3):252-5. Resumen

126. Laski ME, Kurtzman NA. Evaluation of acid-base disorders from the urine. In: Seldin DW and Giebisch G, eds. The regulation of acid-base balance. New York, NY: Raven Press; 1989:265-83.

127. Vallo A, Rodriguez-Soriano J. Oral phosphate-loading test for the assessment of distal urinary acidification in children. Miner Electrolyte Metab. 1984;10(6):387-90. Resumen

128. Halperin ML, Goldstein MB, Haig A, et al. Studies on the pathogenesis of type 1 (distal) renal tubular acidosis as revealed by the urinary PCO2 tensions. J Clin Invest. 1974 Mar;53(3):669-77. Resumen

129. Stinebaugh BJ, Shloeder FX, Gharafry E, et al. Mechanism by which neutral phosphate infusion elevates urine PCO2. J Lab Clin Med. 1977 May;89(5):946-58. Resumen

130. Emmett M, Narins RG. Clinical use of the anion gap. Medicine (Baltimore). 1977 Jan;56(1):38-54. Resumen

131. Soleimani M, Rastegar A. Pathophysiology of renal tubular acidosis: core curriculum 2016. Am J Kidney Dis. 2016 Sep;68(3):488-98.Texto completo  Resumen

132. Halperin ML, Margolis BL, Robinson LA, et al. The urine osmolal gap: a clue to estimate urine ammonium in "hybrid" types of metabolic acidosis. Clin Invest Med. 1988 Jun;11(3):198-202. Resumen

133. Andreucci E, Bianchi B, Carboni I, et al. Inner ear abnormalities in four patients with dRTA and SNHL: clinical and genetic heterogeneity. Pediatr Nephrol. 2009 Nov;24(11):2147-53. Resumen

134. Mul D, Grote FK, Goudriaan JR, et al. Should blood gas analysis be part of the diagnostic workup of short children? Auxological data and blood gas analysis in children with renal tubular acidosis. Horm Res Paediatr. 2010;74(5):351-7. Resumen

135. Hall PW III, Piscator M, Vasiljevic M, et al. Renal function studies on individuals with the tubular proteinuria of endemic Balkan nephropathy. Q J Med. 1972 Oct;41(164):385-93. Resumen

136. Oduwole AO, Giwa OS, Arogundade RA. Relationship between rickets and incomplete distal renal tubular acidosis in children. Ital J Pediatr. 2010 Aug 11;36:54.Texto completo  Resumen

137. Wrong O, Davies W. The excretion of acid in renal disease. Q J Med. 1959 Apr;28(110):259-313. Resumen

138. Walsh SB, Shirley DG, Wrong OM, et al. Urinary acidification assessed by simultaneous furosemide and fludrocortisones treatment: an alternative to ammonium chloride. Kidney Int. 2007 Jun;71(12):1310-6. Resumen

139. Alon U, Hellerstein S. Assessment and interpretation of the tubular threshold for phosphate in infants and children. Pediatr Nephrol. 1994 Apr;8(2):250-1. Resumen

140. Brodehl J. Fanconi syndrome. In: Davison AM, Cameron JS, Grunfeld JP, et al, eds. Oxford textbook of clinical nephrology. 2nd ed. New York, NY: Oxford University Press; 1998:1019-37.

141. Domrongkitchaiporn S, Khositseth S, Stitchantrakul W, et al. Dosage of potassium citrate in the correction of urinary abnormalities in pediatric distal renal tubular acidosis patients. Am J Kidney Dis. 2002 Feb;39(2):383-91. Resumen

142. Rodriguez-Soriano J, Vallo A, Castillo G, et al. Natural history of primary distal renal tubular acidosis treated since infancy. J Pediatr. 1982 Nov;101(5):669-76. Resumen

143. An J, Braam B. Complete hypokalemic quadriparesis as a first presentation of Sjögren syndrome. Can J Kidney Health Dis. 2018 May 10;5:2054358118774536.Texto completo  Resumen

144. Bruce LJ, Cope DL, Jones GK, et al. Familial distal renal tubular acidosis is associated with mutations in the red cell anion exchanger (Band 3, AE1) gene. J Clin Invest. 1997 Oct 1;100(7):1693-707. Resumen

145. McSherry E, Morris RC Jr. Attainment and maintenance of normal stature with alkali therapy in infants and children with classic renal tubular acidosis. J Clin Invest. 1978 Feb;61(2):509-27. Resumen

146. Nash MA, Torrado AD, Greifer I, et al. Renal tubular acidosis in infants and children. Clinical course, response to treatment, and prognosis. J Pediatr. 1972 May;80(5):738-48. Resumen

147. Pitt B, Anker SD, Bushinsky DA, et al. Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial. Eur Heart J. 2011 Apr;32(7):820-8.Texto completo  Resumen

148. Stavros F, Yang A, Leon A, et al. Characterization of structure and function of ZS-9, a K+ selective ion trap. PLoS One. 2014;9(12):e114686.Texto completo  Resumen

149. Roger SD, Lavin PT, Lerma EV, et al. Long-term safety and efficacy of sodium zirconium cyclosilicate for hyperkalaemia in patients with mild/moderate versus severe/end-stage chronic kidney disease: comparative results from an open-label, Phase 3 study. Nephrol Dial Transplant. 2021 Jan 1;36(1):137-50.Texto completo  Resumen

150. Clericetti CM, Milani GP, Lava SAG, et al. Hyperammonemia associated with distal renal tubular acidosis or urinary tract infection: a systematic review. Pediatr Nephrol. 2018 Mar;33(3):485-91. Resumen

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad